Patent · US Active

Compositions, methods, and kits for amplifying nucleic acids

US11225686B2 · kind B2 · utility

0Cited by
11References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 17, 2020
Grant dateJan 18, 2022
Priority date
Expiry dateJan 17, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/16
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present teachings are directed to compositions, methods, and kits for amplifying target nucleic acids while reducing non-specific fluorescence and undesired amplification products, sometimes referred to as secondary amplification products or spurious side-products. The enzyme inhibitors disclosed herein comprise a nucleotide sequence and at least one quencher. Complexes comprising an enzyme inhibitor associated with an enzyme, wherein at least one enzymatic activity of the enzyme is inhibited, are also provided. Methods for amplifying a target nucleic acid while reducing undesired amplification products are disclosed, as are methods for reducing non-specific fluorescence. Kits for expediting the performance of certain disclosed methods are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.